🇺🇸 FDA

Company profile · Sponsor

UCB

UCB Pharma

EF2CC8C · NMPA pharma ANDERLECHT, CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

UCB (EF2CC8C) is a pharma company. headquartered in ANDERLECHT, CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EF2CC8C
Exchange NMPA
Company type pharma
Headquarters ANDERLECHT, CN

Pipeline (2)

Search pipeline →

  1. Brivaracetam

    UCB

    Epilepsy

    phase 3 small molecule completed

    1 trial

  2. Levetiracetam

    UCB

    Epilepsy

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is UCB?

UCB (EF2CC8C) is a pharma company. headquartered in ANDERLECHT, CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does UCB sponsor?

We track 2 ClinicalTrials.gov-linked programs for UCB, including Brivaracetam and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does UCB company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.